W STRATEGIES, LLC for GLAXOSMITHKLINE
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Regulatory and legislative proposals in the Administrations Blueprint. CMS rule dealing with removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
H.R.269: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) reauthorization including the Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018. S.1260: Reducing Administrative Costs and Burdens in Health Care Act of 2019. Proposed legislation around cosmetics reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.